Precision Medical Industry Report: The tumor gene sequencing market is about to break out

In August 2015, the Ministry of Science and Technology issued the “Methods for the Management of Stem Cell Clinical Trials”, which opened up clinical trials of stem cells under limited conditions. On December 31, 2015, the National Health and Family Planning Commission issued the “Notice on Extending the Planning and Setting Time of Cord Blood Hematopoietic Stem Cell Bank”, and decided that before 2020, there will be no new settings based on the current only seven stem cell banks. Cord blood bank. Therefore, the future development direction of the stem cell industry should be an extension of the middle and lower reaches of the industrial chain.

Advances in genetic testing technology, tumor genetic testing is welcoming

The popularity of genetic testing and technological breakthroughs are the main factors driving the rapid growth of the market. On the one hand, the relationship between more and more disease pre-gene mutations has been proven, and the accuracy of genetic testing is increasing year by year. On the other hand, with the maturity of sequencing technology, the decline in sequencing costs will increase the penetration rate of gene sequencing services, and thus promote the rapid development of the market.

Tumors will become the largest application market for gene sequencing. On the one hand, with the aging of China, environmental pollution and food safety continue to deteriorate, the incidence of cancer is increasing year by year; on the other hand, the individual differences of cancer are large, the application of traditional treatment methods is very limited, and tumor gene detection can provide effective Medication guidance.

The gene sequencing market will reach a total size of 200 US dollars, and the tumor gene sequencing market is about to break out.

According to BBC Research, the global gene sequencing market in 2007 was 790 million US dollars. By 2013, the market size was 4.5 billion US dollars. It is expected that the global gene sequencing market will reach 11 billion US dollars in 2018, with a compound annual growth rate of 29%.

According to Illumina's estimates, the market for gene sequencing services will have a capacity of $20 billion over the next few years, including $12 billion in oncology, $5 billion in life sciences, $2 billion in fertility and genetic health, and $1 billion in other applications. At this stage, domestically sequenced clinical services are used more in prenatal testing, and the tumor gene sequencing market is about to break out.

Stem cell midstream and downstream industries: huge therapeutic needs and market space

Stem cell therapy currently conducts a number of clinical trials worldwide, covering more than 140 diseases. The stem cell market is expected to reach $10 billion in 2016, with stem cell treatment accounting for more than half of the market. It is estimated that by 2020, the global stem cell industry will reach 400 billion US dollars. Stem cell storage accounts for only 15.2% of the global stem cell industry market share. Stem cell therapy accounts for more than 50% of the global stem cell industry market share and will expand further. In the past, due to the influence of policies, China's middle and lower reaches industries are in a state of stagnation. At present, with the limited opening of clinical trials, the layout of enterprises in the middle and lower reaches of the stem cell field is particularly important.

The overall industry benefits, key enterprises focus on the layout of the middle and lower reaches of the industry

We recommend focusing on large-scale mergers and acquisitions of upstream cell banks of enterprises, transactions in key technology patents related to the midstream and downstream industries, publication of clinical trial results, and approval of the marketing of stem cell drugs or technologies.

L-Tryptophan

L-Tryptophan,L Tryptophan Powder,L Tryptophan 73-22-3,Feed Grade L Tryptophan

CHANGZHOU GUANGHUI FOOD INGREDIENTS CO.,LTD , https://www.gsweetfood.com